SK
Shailendra Kumar
About Shailendra Kumar
Data last updated:
Shailendra Kumar is a Director at Nexgen Bio Sciences Private Limited (since 2017) and Director at Birsa Polyclinic Private Limited (since 2020). The companies operate in Trading and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹1.76 Cr; the largest is Nexgen Bio Sciences Private Limited at ₹1.64 Cr (FY 2025). Earlier, Shailendra Kumar was a Director at Medberg Pharma Private Limited (from 2014).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 19 Jun 2017 | 2010 | ₹1.64 Cr (FY 2025) | Active | |
| Director | 07 Oct 2020 | 2020 | ₹11.6 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 13 Oct 2014 | 2014 | ₹1.3 Lakh (FY 2017) | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Shailendra Kumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rinki Kumari Tiwari | 08746619 | Nexgen Bio Sciences Private Limited , Birsa Polyclinic Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shailendra Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shailendra Kumar
Shailendra Kumar currently holds 2 directorships: Nexgen Bio Sciences Private Limited (Director, since 19 Jun 2017, revenue ₹1.64 Cr (FY 2025)); Birsa Polyclinic Private Limited (Director, since 07 Oct 2020, revenue ₹11.6 Lakh (FY 2025)).
Shailendra Kumar was first appointed on 13 Oct 2014 as Director at Medberg Pharma Private Limited. The most recent appointment on record is 07 Oct 2020 at Birsa Polyclinic Private Limited.
The 2 current companies of Shailendra Kumar that report revenue have a combined latest revenue of ₹1.76 Cr: Nexgen Bio Sciences Private Limited ₹1.64 Cr (FY 2025); Birsa Polyclinic Private Limited ₹11.6 Lakh (FY 2025).
Shailendra Kumar held 1 earlier board appointment: Medberg Pharma Private Limited (Director, from 13 Oct 2014).
The current boards of Shailendra Kumar's companies include Rinki Kumari Tiwari (Nexgen Bio Sciences Private Limited).